Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
about
Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence.Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units.Antineoplastic agents. 592. Highly effective cancer cell growth inhibitory structural modifications of dolastatin 10.In vitro interactions of approved and experimental drugs against Candida drugs against Candida spp.
P2860
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
@ast
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
@en
type
label
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
@ast
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
@en
prefLabel
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
@ast
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
@en
P2093
P2860
P1476
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans
@en
P2093
Dominique B Hoelzinger
George R Pettit
Günther Winkelmann
Michael E Berens
Robin K Pettit
P2860
P304
P356
10.1128/AAC.48.2.561-567.2004
P407
P50
P577
2004-02-01T00:00:00Z